Market Cap (In CNY)
13.88 Billion
Revenue (In CNY)
1.17 Billion
Net Income (In CNY)
492.43 Million
Avg. Volume
1.9 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 78.62-135.58
- PE
- -
- EPS
- -
- Beta Value
- 0.395
- ISIN
- CNE100003MJ5
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. Qing Zhu
- Employee Count
- -
- Website
- https://www.endovastec.com
- Ipo Date
- 2019-07-22
- Details
- Shanghai MicroPort Endovascular MedTech Co., Ltd. develops, manufactures, and sells technologies and products in the healthcare business. The company primarily offers solutions for aortic and peripheral diseases. Its products include TAA and AAA stent graft systems, balloon inflation catheters, and PTA balloon dilatation catheters. The company was founded in 2012 and is based in Shanghai, the People's Republic of China. Shanghai MicroPort Endovascular MedTech Co., Ltd. is a subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd.
More Stocks
-
ELTLFElementos Limited
ELTLF
-
BJURFBonjour Holdings Limited
BJURF
-
BLGOBuligo Capital Ltd
BLGO
-
MGRTMegureit Israel Ltd
MGRT
-
PREMSYNPremier Synthetics Limited
PREMSYN
-
HGGE
-
1441
-
RENE